Terms: = Germ cell tumor AND CgA AND Prognosis
112 results:
1. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
Ingenerf M; Karim H; Auernhammer C; Zacherl M; Wenter V; Winkelmann M; Ricke J; Berger F; Schmid-Tannwald C
Radiol Oncol; 2023 Dec; 57(4):436-445. PubMed ID: 38038419
[TBL] [Abstract] [Full Text] [Related]
2. Biomarkers in neuroendocrine neoplasms.
Zouli C; Zisimopoulou E; Chrisoulidou A
Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.
Zhang Y; Liao JT; Lin Y; Liu C; Wu ZH; Yu B; Sun S; Yu H; Hui XH; Wu XH; Zhao XM; Wang HJ; Zheng Q; Li Y; Hu ZH; Wang JL
J Dig Dis; 2023; 24(8-9):472-479. PubMed ID: 37596865
[TBL] [Abstract] [Full Text] [Related]
5. Neuroendocrine tumor chromogranin A response following synthetic somatostatin analog (lanreotide): Early observations from an isolated duodenal neoplasm .
Sills ES; Wood SH; Tan SL; Ibach DM
Neuro Endocrinol Lett; 2023 Jul; 44(4):265-269. PubMed ID: 37466065
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathological Features of Primary Small cell Neuroendocrine Carcinoma of the Bladder].
Gu YM; Liang XL; Zhang YG; Zhao HY; Jin ML; Li X; Lu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):429-435. PubMed ID: 37407530
[TBL] [Abstract] [Full Text] [Related]
7. Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms.
Kidess E; Giesecke Y; Eichhorn I; Mohr R; Jann H; Fischer C; Wiedenmann B; Roderburg C; Tacke F; Sigal M
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10925-10933. PubMed ID: 37318593
[TBL] [Abstract] [Full Text] [Related]
8. Atypical thymic carcinoid tumor with ectopic ACTH syndrome in a 33-year-old male patient: A rare case report and literature review.
Li LY; Zhao HY; Tong HC; Li YC; Xu HT; Ma S; Yang LH; Zhang WL; Wildes T; Wang E
Medicine (Baltimore); 2023 Jun; 102(22):e33847. PubMed ID: 37266641
[TBL] [Abstract] [Full Text] [Related]
9. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
10. [Clinical analysis of 11 patients with neuroendocrine carcinoma in maxillofacial region].
Lin S; Guo RY; Liu KY; Mi HY; Wang MY; Fu HJ; Li R
Zhonghua Kou Qiang Yi Xue Za Zhi; 2023 Feb; 58(2):151-157. PubMed ID: 36746448
[No Abstract] [Full Text] [Related]
11. Pulmonary Large cell Neuroendocrine Carcinoma.
Yang L; Fan Y; Lu H
Pathol Oncol Res; 2022; 28():1610730. PubMed ID: 36304941
[TBL] [Abstract] [Full Text] [Related]
12. Small cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review.
Lu J; Li Y; Wang J
Front Cell Infect Microbiol; 2022; 12():916506. PubMed ID: 35909972
[TBL] [Abstract] [Full Text] [Related]
13. A Clinicopathological and Molecular Analysis of Sellar/Suprasellar Neurocytoma Mimicking Pituitary Adenoma.
Zhang L; Fu W; Zheng L; Song F; Chen Y; Jiang C; Xing Z; Hu C; Ye Y; Zhang S; Yan X; Wang X
Front Endocrinol (Lausanne); 2022; 13():861540. PubMed ID: 35663322
[TBL] [Abstract] [Full Text] [Related]
14. Cancer germline antigen gene MAGEB2 promotes cell invasion and correlates with immune microenvironment and immunotherapeutic efficiency in laryngeal cancer.
Cui J; Chen Y; Ou Y; Liu G; Wen Q; Zhu W; Liang L; Chen Z; Yang H; Wang L; Wei M
Clin Immunol; 2022 Jul; 240():109045. PubMed ID: 35618211
[TBL] [Abstract] [Full Text] [Related]
15. Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large cell Neuroendocrine Carcinoma.
Wang Y; Chen Y; Yang Z; Qian F; Hu M; Lu J; Zhang Y; Zhang W; Wang K; Han B
Ann Surg Oncol; 2022 Sep; 29(9):5666-5678. PubMed ID: 35543906
[TBL] [Abstract] [Full Text] [Related]
16. SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors.
Yu L; Dong Y; Xue J; Xu S; Wang G; Kuang D; Duan Y
Diagn Pathol; 2022 Jan; 17(1):2. PubMed ID: 34996493
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic stratification for patients with neuroendocrine tumours receiving 177Lu-Dotatate.
Chen L; Gnanasegaran G; Mandair D; Toumpanakis C; Caplin M; Navalkissoor S
Endocr Relat Cancer; 2022 Jan; 29(2):111-120. PubMed ID: 34932018
[TBL] [Abstract] [Full Text] [Related]
18. Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer.
Zarkesh M; Arab N; Tavangar SM; Nozhat Z; Fanaei SM; Hedayati M
Pathol Res Pract; 2022 Jan; 229():153694. PubMed ID: 34929598
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas.
Wu Y; Lai Y; Zhang M; Li Z
Diagn Pathol; 2021 Aug; 16(1):78. PubMed ID: 34454530
[TBL] [Abstract] [Full Text] [Related]
20. Basic Pan-Cancer Analysis of the Carcinogenic Effects of Cyclin-Dependent Kinase 4 (CDK4) in Human Surface tumors.
Wu J; Deng T; Huang Y; Cheng H
J Healthc Eng; 2021; 2021():8493572. PubMed ID: 34422248
[TBL] [Abstract] [Full Text] [Related]
[Next]
